IDEXX Laboratories, Inc. provided earnings guidance for the full year 2022. For the period, the company expects Revenue to be in the range of $3,325 million to $3,365 million. EPS to be in the range of $7.74 to $7.98.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
496 USD | -1.52% | -3.56% | -10.65% |
May. 29 | Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM | |
May. 14 | Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620 | MT |
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- IDEXX Laboratories, Inc. Provides Earnings Guidance for the Full Year 2022